We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Dow Jones leapt to session highs minutes before the close this Monday, up 470 points to a new record 29,950 — +1.6% on the day. This is the second consecutive Monday where excellent news on Covid-19 vaccine potential got the trading week off on the right foot. The S&P 500 rose 1.17%, 42 points, and the small-cap Russell 2000 was up 2.37% on the day — both also closing at new all-time highs. The Nasdaq, which set its historic high the first week of September, posted a 0.80% gain, up 95 points.
Last week, the Pfizer (PFE - Free Report) -BioNTech (BNTX - Free Report) vaccine candidate released performance data that wowed investors with a 90% efficacy rate. Moderna (MRNA - Free Report) did them one better this morning, with a 84.5% success rate reported for its Covid-19 vaccine. Both times, not only Pharma but a multitude of other industries bid up strongly as well. Today, Energy rose 6.5% (+25% so far in November) and Industrials gained 2.5%. Tech, which was also in the green, gained just under 1% on the day.
Of the 11 sectors in the S&P 500, only Healthcare finished down, -0.25%. This might seem odd at a glance — a news story catalyst for market bulls deals directly with the healthcare of citizens around the world, yet the industry itself dips — but it does give some perspective into how pandemic-trampled stocks welcomed some investment rotation today: Carnival Cruise Lines (CCL - Free Report) gained 9.7%, The Gap (GPS - Free Report) was +9.4% and oil-driller HollyFrontier posted gains of 9.17%.
Tomorrow morning, we expect economic reports on Retail Sales, Import Prices and Industrial Production. These are monthly metrics of the general economy which have mostly been improving in increments since the initial grip of the pandemic’s affects on the economy loosened.
Obviously, we are far from out of the woods on the Covid front — in fact, we are at all-time records of infections throughout the country, with dire predicaments now visiting hospital ICUs. But the sooner we see a Covid vaccine on the market, the sooner we will come through the other side of the pandemic. The market has decided the time is right to price this in.
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early. See Zacks' 3 Best Stocks to Play This Trend >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Markets Begin Pricing In Post-Pandemic Reality
The Dow Jones leapt to session highs minutes before the close this Monday, up 470 points to a new record 29,950 — +1.6% on the day. This is the second consecutive Monday where excellent news on Covid-19 vaccine potential got the trading week off on the right foot. The S&P 500 rose 1.17%, 42 points, and the small-cap Russell 2000 was up 2.37% on the day — both also closing at new all-time highs. The Nasdaq, which set its historic high the first week of September, posted a 0.80% gain, up 95 points.
Last week, the Pfizer (PFE - Free Report) -BioNTech (BNTX - Free Report) vaccine candidate released performance data that wowed investors with a 90% efficacy rate. Moderna (MRNA - Free Report) did them one better this morning, with a 84.5% success rate reported for its Covid-19 vaccine. Both times, not only Pharma but a multitude of other industries bid up strongly as well. Today, Energy rose 6.5% (+25% so far in November) and Industrials gained 2.5%. Tech, which was also in the green, gained just under 1% on the day.
Of the 11 sectors in the S&P 500, only Healthcare finished down, -0.25%. This might seem odd at a glance — a news story catalyst for market bulls deals directly with the healthcare of citizens around the world, yet the industry itself dips — but it does give some perspective into how pandemic-trampled stocks welcomed some investment rotation today: Carnival Cruise Lines (CCL - Free Report) gained 9.7%, The Gap (GPS - Free Report) was +9.4% and oil-driller HollyFrontier posted gains of 9.17%.
Tomorrow morning, we expect economic reports on Retail Sales, Import Prices and Industrial Production. These are monthly metrics of the general economy which have mostly been improving in increments since the initial grip of the pandemic’s affects on the economy loosened.
Obviously, we are far from out of the woods on the Covid front — in fact, we are at all-time records of infections throughout the country, with dire predicaments now visiting hospital ICUs. But the sooner we see a Covid vaccine on the market, the sooner we will come through the other side of the pandemic. The market has decided the time is right to price this in.
Questions or comments about this article and/or its author? Click here>>
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>